Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing
- PMID: 27668749
- PMCID: PMC5036845
- DOI: 10.1371/journal.pone.0163458
Identification of Genome-Wide Mutations in Ciprofloxacin-Resistant F. tularensis LVS Using Whole Genome Tiling Arrays and Next Generation Sequencing
Abstract
Francisella tularensis is classified as a Class A bioterrorism agent by the U.S. government due to its high virulence and the ease with which it can be spread as an aerosol. It is a facultative intracellular pathogen and the causative agent of tularemia. Ciprofloxacin (Cipro) is a broad spectrum antibiotic effective against Gram-positive and Gram-negative bacteria. Increased Cipro resistance in pathogenic microbes is of serious concern when considering options for medical treatment of bacterial infections. Identification of genes and loci that are associated with Ciprofloxacin resistance will help advance the understanding of resistance mechanisms and may, in the future, provide better treatment options for patients. It may also provide information for development of assays that can rapidly identify Cipro-resistant isolates of this pathogen. In this study, we selected a large number of F. tularensis live vaccine strain (LVS) isolates that survived in progressively higher Ciprofloxacin concentrations, screened the isolates using a whole genome F. tularensis LVS tiling microarray and Illumina sequencing, and identified both known and novel mutations associated with resistance. Genes containing mutations encode DNA gyrase subunit A, a hypothetical protein, an asparagine synthase, a sugar transamine/perosamine synthetase and others. Structural modeling performed on these proteins provides insights into the potential function of these proteins and how they might contribute to Cipro resistance mechanisms.
Conflict of interest statement
Eureka Genomics provided fee-for-service work for Lawrence Livermore National Lab on DNA sequencing and data analysis. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures




Similar articles
-
Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness.Front Microbiol. 2020 Oct 30;11:593542. doi: 10.3389/fmicb.2020.593542. eCollection 2020. Front Microbiol. 2020. PMID: 33193267 Free PMC article.
-
A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.PLoS One. 2017 Mar 22;12(3):e0174106. doi: 10.1371/journal.pone.0174106. eCollection 2017. PLoS One. 2017. PMID: 28328947 Free PMC article.
-
Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.Vaccine. 2016 Sep 22;34(41):4969-4978. doi: 10.1016/j.vaccine.2016.08.041. Epub 2016 Aug 28. Vaccine. 2016. PMID: 27577555 Free PMC article.
-
Characterization of a Francisella tularensis-Caenorhabditis elegans Pathosystem for the Evaluation of Therapeutic Compounds.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00310-17. doi: 10.1128/AAC.00310-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28652232 Free PMC article.
-
Francisella tularensis vaccines.FEMS Immunol Med Microbiol. 2007 Apr;49(3):315-23. doi: 10.1111/j.1574-695X.2007.00219.x. Epub 2007 Feb 22. FEMS Immunol Med Microbiol. 2007. PMID: 17316369 Review.
Cited by
-
Francisella tularensis: FupA mutation contributes to fluoroquinolone resistance by increasing vesicle secretion and biofilm formation.Emerg Microbes Infect. 2019;8(1):808-822. doi: 10.1080/22221751.2019.1615848. Emerg Microbes Infect. 2019. PMID: 31164053 Free PMC article.
-
Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02277-16. doi: 10.1128/AAC.02277-16. Print 2017 Apr. Antimicrob Agents Chemother. 2017. PMID: 28167561 Free PMC article.
-
Peptidoglycan enzymes of Francisella: Roles in cell morphology and pathogenesis, and potential as therapeutic targets.Front Microbiol. 2023 Jan 12;13:1099312. doi: 10.3389/fmicb.2022.1099312. eCollection 2022. Front Microbiol. 2023. PMID: 36713212 Free PMC article. Review.
-
Genetic Determinants of Antibiotic Resistance in Francisella.Front Microbiol. 2021 May 12;12:644855. doi: 10.3389/fmicb.2021.644855. eCollection 2021. Front Microbiol. 2021. PMID: 34054749 Free PMC article. Review.
-
A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor Species.Int J Mol Sci. 2020 Feb 29;21(5):1669. doi: 10.3390/ijms21051669. Int J Mol Sci. 2020. PMID: 32121349 Free PMC article.
References
-
- Lindler LE, Fan W. Development of a 5' nuclease assay to detect ciprofloxacin resistant isolates of the biowarfare agent Yersinia pestis. Mol Cell Probes. 2003;17:41–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources